Hap Trading, LLC Syros Pharmaceuticals, Inc. Put Options Transaction History

Hap Trading, LLC

  • $840 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$3.26 - $4.66 $56,397 - $80,618
-17,300 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
$4.08 - $5.66 $3,672 - $5,094
900 Added 5.49%
17,300 $52,000
Q2 2021

Aug 11, 2021
BUY
$5.01 - $7.48 $82,164 - $122,672
16,400 New
16,400 $42,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email